Related Experiment Videos
Depressed classical complement pathway activities in chronic lymphocytic leukaemia
Insights
Chronic lymphocytic leukemia (CLL) patients often show reduced classical complement pathway activity. This involves low levels of C1 and C4 complement components, suggesting a frequent immune system deficiency in CLL.
Area of Science:
- Immunology
- Hematology
- Biochemistry
Background:
- The complement system is crucial for immune response.
- Complement deficiencies can impact disease progression.
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
Purpose of the Study:
- To investigate complement pathway activity in patients with chronic lymphocytic leukemia (CLL).
- To assess levels of specific complement components (C1, C4, C3, factor B, C1 inhibitor) in CLL patients.
- To determine the frequency of complement pathway alterations in CLL.
Main Methods:
- Serum samples from 46 CLL patients were analyzed.
- Haemolytic activities of classical and alternative complement pathways were measured.
- Levels of C1, C4, C3, factor B, and C1 inhibitor (C1-INH) were quantified.
Main Results:
- Significantly decreased mean C1 and C4 levels were observed in CLL patients.
- Low or low-normal haemolytic activity of C1 and C4 was found in over 50% of samples.
- A complement profile resembling acquired C1 inhibitor (C1-INH) deficiency was noted in some patients.
Conclusions:
- Depressed classical complement pathway activity is a common finding in chronic lymphocytic leukemia (CLL).
- These alterations may contribute to the pathophysiology or clinical course of CLL.
- Further research is warranted to understand the clinical implications of complement deficiencies in CLL.
Abstract:
Haemolytic activities of the classical and alternative complement pathways, and levels of C1, C4, C3, factor B and C1 inhibitor (C1-INH) were measured in 85 serum samples from 46 patients with chronic lymphocytic leukaemia (CLL). Significantly decreased mean C1 and C4 levels were found, and the haemolytic activities of these components were low or low normal in more than 50% of the sera tested. In 15 sera from 5 patients a complement profile characteristic of acquired C1-IHN deficiency was observed. These results indicate that the depression of the activity of the classical complement pathway is a frequently occurring feature in CLL.